Cathie Wood Beam Therapeutics Inc. Transaction History
Ark Investment Management LLC
- $10.5 Billion
- Q3 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 6,531,099 shares of BEAM stock, worth $156 Million. This represents 1.52% of its overall portfolio holdings.
Number of Shares
6,531,099
Previous 7,626,139
14.36%
Holding current value
$156 Million
Previous $179 Million
10.45%
% of portfolio
1.52%
Previous 1.63%
Shares
16 transactions
Others Institutions Holding BEAM
# of Institutions
229Shares Held
71.8MCall Options Held
283KPut Options Held
233K-
Farallon Capital Management LLC San Francisco, CA7.91MShares$189 Million0.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$189 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$183 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL5.44MShares$130 Million74.72% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.55MShares$85 Million0.06% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.68B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...